<DOC>
	<DOCNO>NCT00328497</DOCNO>
	<brief_summary>This single center , open-label study evaluate safety efficacy Panzem ( 2-methoxyestradiol , 2ME2 ) Nanocrystal Dispersion ( NCD ) administer orally recombinant human monoclonal antibody vascular endothelial growth factor ( bevacizumab ) administer intravenously , patient locally advance metastatic carcinoid tumor .</brief_summary>
	<brief_title>A Combination Study Determine Safety Efficacy Panzem NCD With Avastin Metastatic Carcinoid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>2-methoxyestradiol</mesh_term>
	<criteria>Histologically document locally unresectable metastatic carcinoid neuroendocrine tumor Measurable disease , accord RECIST , least one lesion unidimensionally measurable conventional technique great equal 2 cm diameter , spiral CT great equal 1 cm diameter 18 year old Laboratory data include ( next 7 bullet point ) : Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) less 2.5 time upper limit normal ( less 5 time upper limit normal liver metastasis present ) Total bilirubin less equal 2 mg/dL Serum creatinine less equal 1.5 mg/dL Total white blood cell count great 3,500/mm3 Absolute neutrophil count great equal 1,500/mm3 International normalize ratio less equal 1.5 Platelets great equal 100,000/mm3 Agree use effective contraceptive method Have ECOG performance status le 2 Life expectancy great 12 week Ability understand requirement study , provide write consent , agree abibe study restriction Pregnant nursing , refusal use appropriate birth control An active infection Have history myocardial infarction angina pectoris/angina equivalent last 12 month ( patient may antianginal medication symptom fully control ) , uncontrolled congestive heart failure Have apparent central nervous system metastasis carcinomatous meningitis Have active cancer addition carcinoid tumor within last 5 year , exception superficial skin cancer Be receive concurrent treatment therapeutic dos anticoagulant include form heparin Coumadin Have current history severe bleeding Uncontrolled / severe hypertension Previous history nephrotic syndrome Urine protein : creatinine ratio great equal 1.0 screening Have receive radiotherapy chemotherapy within previous 4 week Participated clinical trial involve conventional investigational drug device within previous 4 week Have major surgery within 4 week plan undergo elective surgery treatment Additional uncontrolled serious medical condition psychiatric illness Have condition likely interfere regular followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>